PortfoliosLab logo
Qilian International Holding Group Limited (QLI)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG7307E1070

IPO Date

Jan 12, 2021

Highlights

Market Cap

$38.68M

EPS (TTM)

-$1.10

Year Range

$2.80 - $8.96

Short %

1.79%

Short Ratio

0.76

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart


Loading data...

S&P 500

Returns By Period


QLI

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

0.51%

1M

6.15%

6M

-2.00%

1Y

12.92%

3Y*

12.68%

5Y*

14.19%

10Y*

10.85%

*Annualized

Monthly Returns

The table below presents the monthly returns of QLI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-28.92%-23.36%64.29%6.38%8.99%-16.95%86.03%12.78%14.63%-10.14%86.25%
2023132.75%-19.18%-4.00%-11.20%-21.74%-3.33%-3.10%-5.58%-1.13%-40.91%-1.94%69.08%7.51%
2022-15.09%-12.44%-13.71%6.47%-3.31%13.14%-8.08%-26.92%-10.53%-5.88%10.72%-40.40%-72.11%
2021-30.70%-20.64%-15.36%-1.18%2.17%-10.43%1.19%-3.05%-2.18%-7.67%-18.50%-12.83%-73.50%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of QLI is 70, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of QLI is 7070
Overall Rank
The Sharpe Ratio Rank of QLI is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of QLI is 7575
Sortino Ratio Rank
The Omega Ratio Rank of QLI is 7171
Omega Ratio Rank
The Calmar Ratio Rank of QLI is 7575
Calmar Ratio Rank
The Martin Ratio Rank of QLI is 7171
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Qilian International Holding Group Limited (QLI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There isn't enough data available to calculate the Sharpe ratio for Qilian International Holding Group Limited. This metric is based on the past 12 months of trading data. Please check back later for updated information.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History

Qilian International Holding Group Limited provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


6.49%$0.00$0.05$0.10$0.15$0.20$0.252023
Dividends
Dividend Yield
PeriodTTM2023
Dividend$0.00$0.25

Dividend yield

0.00%6.49%

Monthly Dividends

The table displays the monthly dividend distributions for Qilian International Holding Group Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.25$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.25

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Qilian International Holding Group Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Qilian International Holding Group Limited was 96.73%, occurring on Nov 15, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.73%Jan 14, 2021715Nov 15, 2023
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Qilian International Holding Group Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Qilian International Holding Group Limited, comparing actual results with analytics estimates.


0.000.050.100.15AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023
0.03
0
Actual
Estimate

Valuation

The Valuation section provides an overview of how Qilian International Holding Group Limited is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for QLI relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, QLI has a P/S ratio of 0.8. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for QLI in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, QLI has a P/B value of 1.2. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items